News Chart Sarepta Therapeutics, Inc.

Equities

SRPT

US8036071004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
131.8 ^USD	-0.36%		-1.38%	+36.70%

May. 02	Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says	MT
May. 02	UBS Adjusts Price Target on Sarepta Therapeutics to $173 From $167, Maintains Buy Rating	MT

44fdadbaf533ba6761242.lIHnzJ4rjYWsdZxN3W2tffB6JVUEbY_j8NE22-13Ht4.1uu2-NUYxd_UB9g9pTjZFpYVVzpPQPyLu5txmKMaKrfL-4q9133XvP032Q~0b2b99782cc12625c617a7d13ea0b99c